UK PPE firm, Globus Group, is expanding its UK manufacturing capacity to meet the increasing demand for high performance PPE for the UK’s healthcare sector.
The company will be creating hundreds of new jobs due to multi-million-pound contracts to make high-performance FFP3 face masks for frontline NHS staff. The most recent contract with Department for Health and Social Care follows a contract won by Globus Group company Alpha Solway for NHS Scotland.
This news comes in the wake of the DHSC’s announcement that increases in domestic PPE manufacture will mean that 70% of the UK’s expected demand for PPE will be manufactured in the UK. Since February 2020, more than 3.5 billion items of PPE have been distributed to frontline healthcare workers across the UK, and demand is expected to increase to cope with the second wave of COVID-19.
Globus Director, Steven Binnie, said: “We have committed tens of millions of pounds in capital investment for enhancement and expansion of our UK manufacturing capabilities. This will ensure we provide a long-term, sustainable, ongoing supply of PPE to NHS professionals, as well as key industry workers. At full capacity, our UK facilities will be capable of annual production of 200 million FFP3 masks, 100 million FFP2 masks, 1 billion Type IIR medical masks, and 22 million visors.”
Globus Group has also been awarded a £50m+ PPE contract with NHS Scotland for Alpha Solway to produce FFP3 respirator and Type IIR masks, fulfilling 87% of Scotland’s health and social care needs. FFP3 masks offer the highest level of protection against fine particles, including viruses and bacteria.
